Biotech · Private company
Equilibre Biopharmaceuticals B.V.
Track this companyFree. Adds Equilibre Biopharmaceuticals B.V. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- EQU-001Phase 2 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
- EQU-001Phase 2 · Focal Onset SeizuresClinicalTrials.gov · fetched Nov 12, 2026
- EQU-001Phase 1 · Safety IssuesClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of EQU-001 for Uncontrolled Focal Onset SeizuresPHASE2 · TERMINATED · started Dec 27, 2022ClinicalTrials.gov NCT05473442 · fetched Nov 12, 2026
- Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With EpilepsyPHASE2 · UNKNOWN · started Aug 31, 2021ClinicalTrials.gov NCT05063877 · fetched Nov 12, 2026
- Safety, Tolerability, and Pharmacokinetics of EQU-001 in Healthy VolunteersPHASE1 · COMPLETED · started Jul 6, 2021ClinicalTrials.gov NCT05004571 · fetched Nov 12, 2026